371 related articles for article (PubMed ID: 21371437)
1. Elevated invasive potential of glioblastoma stem cells.
Cheng L; Wu Q; Guryanova OA; Huang Z; Huang Q; Rich JN; Bao S
Biochem Biophys Res Commun; 2011 Mar; 406(4):643-8. PubMed ID: 21371437
[TBL] [Abstract][Full Text] [Related]
2. Targeting role of glioma stem cells for glioblastoma multiforme.
Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
[TBL] [Abstract][Full Text] [Related]
3. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.
Huang Z; Cheng L; Guryanova OA; Wu Q; Bao S
Protein Cell; 2010 Jul; 1(7):638-55. PubMed ID: 21203936
[TBL] [Abstract][Full Text] [Related]
6. L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.
Cheng L; Wu Q; Huang Z; Guryanova OA; Huang Q; Shou W; Rich JN; Bao S
EMBO J; 2011 Mar; 30(5):800-13. PubMed ID: 21297581
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
[TBL] [Abstract][Full Text] [Related]
8. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
9. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
11. The effects of type I interferon on glioblastoma cancer stem cells.
Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.
Cheng L; Huang Z; Zhou W; Wu Q; Donnola S; Liu JK; Fang X; Sloan AE; Mao Y; Lathia JD; Min W; McLendon RE; Rich JN; Bao S
Cell; 2013 Mar; 153(1):139-52. PubMed ID: 23540695
[TBL] [Abstract][Full Text] [Related]
14. Astrocytes enhance the invasion potential of glioblastoma stem-like cells.
Rath BH; Fair JM; Jamal M; Camphausen K; Tofilon PJ
PLoS One; 2013; 8(1):e54752. PubMed ID: 23349962
[TBL] [Abstract][Full Text] [Related]
15. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.
Zhou W; Ke SQ; Huang Z; Flavahan W; Fang X; Paul J; Wu L; Sloan AE; McLendon RE; Li X; Rich JN; Bao S
Nat Cell Biol; 2015 Feb; 17(2):170-82. PubMed ID: 25580734
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
[TBL] [Abstract][Full Text] [Related]
17. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
[TBL] [Abstract][Full Text] [Related]
18. Targeting glioblastoma stem cells: cell surface markers.
He J; Liu Y; Lubman DM
Curr Med Chem; 2012; 19(35):6050-5. PubMed ID: 22963566
[TBL] [Abstract][Full Text] [Related]
19. Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.
Bai Y; Lathia JD; Zhang P; Flavahan W; Rich JN; Mattson MP
Glia; 2014 Oct; 62(10):1687-98. PubMed ID: 24909307
[TBL] [Abstract][Full Text] [Related]
20. Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor.
Orzan F; De Bacco F; Crisafulli G; Pellegatta S; Mussolin B; Siravegna G; D'Ambrosio A; Comoglio PM; Finocchiaro G; Boccaccio C
Stem Cells; 2017 Nov; 35(11):2218-2228. PubMed ID: 28895245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
